These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32283243)

  • 1. Treatment considerations for patients with pemphigus during the COVID-19 pandemic.
    Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS
    J Am Acad Dermatol; 2020 Jun; 82(6):e235-e236. PubMed ID: 32283243
    [No Abstract]   [Full Text] [Related]  

  • 2. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.
    Zhang X; Song K; Tong F; Fei M; Guo H; Lu Z; Wang J; Zheng C
    Blood Adv; 2020 Apr; 4(7):1307-1310. PubMed ID: 32243501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab administration in a refractory case of COVID-19.
    Dastan F; Nadji SA; Saffaei A; Tabarsi P
    Int J Antimicrob Agents; 2020 Aug; 56(2):106043. PubMed ID: 32502524
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
    De Luna G; Habibi A; Deux JF; Colard M; Pham Hung d'Alexandry d'Orengiani AL; Schlemmer F; Joher N; Kassasseya C; Pawlotsky JM; Ourghanlian C; Michel M; Mekontso-Dessap A; Bartolucci P
    Am J Hematol; 2020 Jul; 95(7):876-878. PubMed ID: 32282956
    [No Abstract]   [Full Text] [Related]  

  • 5. May IL-17 have a role in COVID-19 infection?
    Megna M; Napolitano M; Fabbrocini G
    Med Hypotheses; 2020 Jul; 140():109749. PubMed ID: 32339777
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab.
    Mohebbi N; Abedini A; Lashgari R; Razavi F; Varahram M; Kiani A
    Adv Respir Med; 2020; 88(5):468-469. PubMed ID: 33169824
    [No Abstract]   [Full Text] [Related]  

  • 7. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.
    Michot JM; Albiges L; Chaput N; Saada V; Pommeret F; Griscelli F; Balleyguier C; Besse B; Marabelle A; Netzer F; Merad M; Robert C; Barlesi F; Gachot B; Stoclin A
    Ann Oncol; 2020 Jul; 31(7):961-964. PubMed ID: 32247642
    [No Abstract]   [Full Text] [Related]  

  • 8. Early tocilizumab treatment could improve survival among COVID-19 patients.
    Campins L; Boixeda R; Perez-Cordon L; Aranega R; Lopera C; Force L
    Clin Exp Rheumatol; 2020; 38(3):578. PubMed ID: 32456769
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.
    Jiménez-Brítez G; Ruiz P; Soler X
    Med Clin (Barc); 2020 Nov; 155(9):410-411. PubMed ID: 32718713
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 in hem/onc news.
    Schuyler D
    Clin Adv Hematol Oncol; 2020 May; 18(5):248. PubMed ID: 32628651
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.
    Assimakopoulos SF; Seintis F; Marangos M
    Med Hypotheses; 2020 Oct; 143():109926. PubMed ID: 32485316
    [No Abstract]   [Full Text] [Related]  

  • 12. Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
    Zhang Y; Zhong Y; Pan L; Dong J
    Drug Discov Ther; 2020; 14(2):100-102. PubMed ID: 32378647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative management of Covid-19 infection.
    Atrah HI
    Scott Med J; 2020 Aug; 65(3):72-75. PubMed ID: 32638647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge.
    Carnero Contentti E; Correa J
    Mult Scler Relat Disord; 2020 Jun; 41():102097. PubMed ID: 32278860
    [No Abstract]   [Full Text] [Related]  

  • 17. Thoughts on COVID-19 and autoimmune diseases.
    Askanase AD; Khalili L; Buyon JP
    Lupus Sci Med; 2020; 7(1):e000396. PubMed ID: 32341791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
    Hoiland RL; Stukas S; Cooper J; Thiara S; Chen LYC; Biggs CM; Hay K; Lee AYY; Shojania K; Abdulla A; Wellington CL; Sekhon MS
    Br J Haematol; 2020 Aug; 190(3):e150-e154. PubMed ID: 32584416
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient.
    Benhadou F; Del Marmol V
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e363-e364. PubMed ID: 32379925
    [No Abstract]   [Full Text] [Related]  

  • 20. How to manage rheumatic patients during the coronavirus pandemic.
    Parisi S; Ditto MC; Finucci A; Fusaro E
    Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.